Pharmaco - Press Releases

Date	Title	Company
10-May-2023	STIMULAN now available in South Africa to treat bacterial infection	Biocomposites
10-May-2023	Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert	Mainz BioMed N.V.
10-May-2023	BRIM plans to launch a new funding round to accelerate late-stage clinical trial and initiate a new phase 2 trial for orphan drug BRM424 in the U.S	Sciad Newswire
10-May-2023	SYNLAB AG: SYNLAB reports strong start to fiscal year 2023	SYNLAB AG
10-May-2023	PharmaSGP with a significant leap in revenue in Q1 2023 – EBITDA grows by more than 40%	PharmaSGP Holding SE
10-May-2023	Formycon Announces Participation in International Investor Conferences in Q2/2023	Formycon AG
10-May-2023	Q1 2023 Qualitative Update: Business Performance In Line With Full-Year Trajectory	Lonza Group AG
09-May-2023	PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs	PolyPeptide Group
09-May-2023	Just – Evotec Biologics launches tech partnership for biosimilars development and commercial manufacturing	Evotec SE
09-May-2023	Just – Evotec Biologics enters strategic biosimilars partnership with Sandoz	Evotec SE
09-May-2023	AEVIS VICTORIA SA – Ordinary General Meeting of Shareholders: all proposals approved	AEVIS VICTORIA SA
09-May-2023	Biotest AG: Annual General Meeting of Biotest AG elects Raimon Grifols Roura to the Supervisory Board	Biotest AG
09-May-2023	High Demand: Vetter Expands Production Capacities and Services Offered at Its Austrian Site	B3C newswire
09-May-2023	Farxiga extended in the US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients	AstraZeneca
09-May-2023	Moberg Pharma´s Interim report January - March 2023	Moberg Pharma
09-May-2023	SYNLAB AG: SYNLAB invests in new, cutting-edge laboratory in Munich and further expands its leading position in the region (news with additional features)	SYNLAB AG
09-May-2023	Biophytis has requested a pre-submission meeting with the EMA for the Marketing Authorisation of Sarconeos (BIO101) for the treatment of COVID-19	Biophytis
09-May-2023	APONTIS PHARMA in Q1 2023 records decline in sales and earnings as expected – 2023 as a transition year in focusing on Single Pills	APONTIS PHARMA AG
08-May-2023	Annual General Meeting of Kuros Biosciences approves all resolutions	Kuros Biosciences AG
08-May-2023	CureVac Announces Dosing of First Participant in Combined Phase 1/2 Study of Multivalent, Modified Influenza Vaccine Candidates Developed in Collaboration with GSK	CureVac